Neurocognitive battery feasible in 3-year-olds during leukemia treatment

A brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a study published online Dec. 9 in Pediatric Blood & Cancer.

Facebook Comments